Subsequent Events	12 Months Ended
Dec. 31, 2016
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events Worker's Compensation Insurance On January 1, 2017, the Company lapsed on its worker's compensation insurance. The Company estimates its remaining self-insured worker’s compensation liability based on past claims experience, and has an accrued liability to cover estimated future costs. The accrued liability was approximately $1.2 million and $1.1 million at December 31, 2016 and December 31, 2015, respectively. There can be no assurance that actual results will not materially differ from the Company's estimates. NYSE American Deficiency Letter On January 10, 2017, the Company received a Deficiency Letter from the NYSE American that it was not in compliance with certain NYSE American continued listing standards relating to stockholders’ equity as of September 30, 2016. Specifically, the Deficiency Letter stated that the Company is not in compliance with Section 1003(a)(1) (requiring stockholders’ equity of $2.0 million or more if it has reported losses from continuing operations and/or net losses in two of its three most recent fiscal years), Section 1003(a)(ii) (requiring stockholders’ equity of $4.0 million or more if it has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years); and Section 1003(a)(iii) (requiring stockholders’ equity of $6.0 million or more if it has reported losses from continuing operations and/or net losses in its five most recent fiscal years). The Deficiency Letter noted that the Company had a stockholders’ equity deficit of $(10.3) million as of September 30, 2016, and has reported net losses in its five most recent fiscal years. The Company was required to, and did, submit a plan to the NYSE American by February 9, 2017, advising of actions it has taken or will take to regain compliance with the continued listing standards by July 10, 2018. On March 17, 2017, the NYSE American notified the Company that it has reviewed the Company’s Plan and determined to accept the Plan and grant a Plan period through July 10, 2018. NYSE Regulation Staff will review the Company periodically for compliance with the initiatives outlined in the Plan. If the Company is not in compliance with the continued listing standards by July 18, 2018, or if the Company does not make progress consistent within the Plan period, NYSE Regulation staff will initiate delisting proceedings as appropriate. On April 18, 2017, the Company received a letter from the NYSE American notifying the Company that it is not in compliance with Section 802.01E of the NYSE Listed Company Manual as a result of its failure to timely file this Annual Report on Form 10-K for the year ended December 31, 2016, with the Securities and Exchange Commission. The filing of this Form 10-K is a condition for the Company’s continued listing on the NYSE American as required by Sections 134 and 1101 of the NYSE Company Guide. The Company filed this Form 10-K on October 18, 2017. The Company must submit a plan to the NYSE American by May 18, 2017, advising of actions it has taken or will take to regain compliance with the continued listed standards. The Company has regained compliance with the NYSE American listing standards by filing this Form 10-K with the SEC prior to October 18, 2017. The letter from the NYSE American also notes that the NYSE American may nevertheless commence delisting proceedings at any time if it deems that the circumstances warrant. Stock Option Issuance On February 8, 2017, an executive officer was granted options to purchase 300,000 shares of common stock, with an exercise price of $0.79. One third of the total amount of options vested and became exercisable as of the grant date and the remaining options vest one-third each year pro rata for two years beginning on February 8, 2018, the first anniversary of the date of the grant. The fair value of the options are amortized over the vesting period. Funding Request Agreement On October 18, 2017, the Company entered into a related party agreement with Rochon Capital Partners to provide short term funding of cash shortages arising in the ordinary course of business through October 31, 2018. This agreement is further discussed in Note (9), Related Party Transactions, to the consolidated financial statements included in this report. Private Placement of Senior Secured Convertible Term Loan The Company has a non-binding principle agreement with a creditor to provide placement of a senior secured convertible term loan in the amount of $5.0 million. The loan would have an interest rate of 14% per annum and a maturity of three years.

Subsequent Events

Worker's Compensation Insurance

On January 1, 2017, the Company lapsed on its worker's compensation insurance. The Company estimates its remaining self-insured worker’s compensation liability based on past claims experience, and has an accrued liability to cover estimated future costs. The accrued liability was approximately $1.2 million and $1.1 million at December 31, 2016 and December 31, 2015, respectively. There can be no assurance that actual results will not materially differ from the Company's estimates.

NYSE American Deficiency Letter

On January 10, 2017, the Company received a Deficiency Letter from the NYSE American that it was not in compliance with certain NYSE American continued listing standards relating to stockholders’ equity as of September 30, 2016. Specifically, the Deficiency Letter stated that the Company is not in compliance with Section 1003(a)(1) (requiring stockholders’ equity of $2.0 million or more if it has reported losses from continuing operations and/or net losses in two of its three most recent fiscal years), Section 1003(a)(ii) (requiring stockholders’ equity of $4.0 million or more if it has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years); and Section 1003(a)(iii) (requiring stockholders’ equity of $6.0 million or more if it has reported losses from continuing operations and/or net losses in its five most recent fiscal years). The Deficiency Letter noted that the Company had a stockholders’ equity deficit of $(10.3) million as of September 30, 2016, and has reported net losses in its five most recent fiscal years. The Company was required to, and did, submit a plan to the NYSE American by February 9, 2017, advising of actions it has taken or will take to regain compliance with the continued listing standards by July 10, 2018. On March 17, 2017, the NYSE American notified the Company that it has reviewed the Company’s Plan and determined to accept the Plan and grant a Plan period through July 10, 2018. NYSE Regulation Staff will review the Company periodically for compliance with the initiatives outlined in the Plan. If the Company is not in compliance with the continued listing standards by July 18, 2018, or if the Company does not make progress consistent within the Plan period, NYSE Regulation staff will initiate delisting proceedings as appropriate.

On April 18, 2017, the Company received a letter from the NYSE American notifying the Company that it is not in compliance with Section 802.01E of the NYSE Listed Company Manual as a result of its failure to timely file this Annual Report on Form 10-K for the year ended December 31, 2016, with the Securities and Exchange Commission. The filing of this Form 10-K is a condition for the Company’s continued listing on the NYSE American as required by Sections 134 and 1101 of the NYSE Company Guide. The Company filed this Form 10-K on October 18, 2017. The Company must submit a plan to the NYSE American by May 18, 2017, advising of actions it has taken or will take to regain compliance with the continued listed standards. The Company has regained compliance with the NYSE American listing standards by filing this Form 10-K with the SEC prior to October 18, 2017. The letter from the NYSE American also notes that the NYSE American may nevertheless commence delisting proceedings at any time if it deems that the circumstances warrant.

Stock Option Issuance

On February 8, 2017, an executive officer was granted options to purchase 300,000 shares of common stock, with an exercise

price of $0.79. One third of the total amount of options vested and became exercisable as of the grant date and the remaining options vest one-third each year pro rata for two years beginning on February 8, 2018, the first anniversary of the date of the grant. The fair value of the options are amortized over the vesting period.

Funding Request Agreement

On October 18, 2017, the Company entered into a related party agreement with Rochon Capital Partners to provide short term funding of cash shortages arising in the ordinary course of business through October 31, 2018. This agreement is further discussed in Note (9), Related Party Transactions, to the consolidated financial statements included in this report.

Private Placement of Senior Secured Convertible Term Loan

The Company has a non-binding principle agreement with a creditor to provide placement of a senior secured convertible term loan in the amount of $5.0 million. The loan would have an interest rate of 14% per annum and a maturity of three years.